Related Experiment Video
Updated: Aug 8, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[Management of AML in the elderly]
Pierre-Yves Dumas1, Arnaud Pigneux1
1CHU de Bordeaux, service d'hématologie clinique et thérapie cellulaire, Inserm U1312, 1, avenue Magellan, 33604 Pessac, France.
New targeted therapies and immunotherapies offer hope for elderly acute myeloid leukemia patients ineligible for chemotherapy. These advances are improving outcomes and may soon influence treatment for younger patients.
Area of Science:
- Hematology
- Oncology
- Clinical Research
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury VI: Nursing Management